These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3921688)
1. Crystallization of excipients in tablets. Ando H; Watanabe S; Ohwaki T; Miyake Y J Pharm Sci; 1985 Feb; 74(2):128-31. PubMed ID: 3921688 [TBL] [Abstract][Full Text] [Related]
2. Conductivity and hardness changes in aged compacts. Bhatia RP; Lordi NG J Pharm Sci; 1979 Jul; 68(7):896-9. PubMed ID: 458612 [TBL] [Abstract][Full Text] [Related]
3. Crystal growth formation in melt extrudates. Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578 [TBL] [Abstract][Full Text] [Related]
4. Relative Humidity Cycling: Implications on the Stability of Moisture-Sensitive Drugs in Solid Pharmaceutical Products. Veronica N; Heng PWS; Liew CV Mol Pharm; 2023 Feb; 20(2):1072-1085. PubMed ID: 36480246 [TBL] [Abstract][Full Text] [Related]
5. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients. Fathy M; Hassan MA; Mohamed FA Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the spontaneous polymorphic transition of pyrazinamide γ form at room temperature by co-spray drying with 1,3-dimethylurea. Baaklini G; Dupray V; Coquerel G Int J Pharm; 2015 Feb; 479(1):163-70. PubMed ID: 25556055 [TBL] [Abstract][Full Text] [Related]
7. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets. Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972 [TBL] [Abstract][Full Text] [Related]
8. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260 [TBL] [Abstract][Full Text] [Related]
9. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers. Naini V; Byron PR; Phillips EM Drug Dev Ind Pharm; 1998 Oct; 24(10):895-909. PubMed ID: 9876544 [TBL] [Abstract][Full Text] [Related]
10. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives. Balani PN; Ng WK; Tan RB; Chan SY J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526 [TBL] [Abstract][Full Text] [Related]
11. Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets. Daraghmeh N; Chowdhry BZ; Leharne SA; Al Omari MM; Badwan AA Mar Drugs; 2015 Mar; 13(4):1739-64. PubMed ID: 25830680 [TBL] [Abstract][Full Text] [Related]
12. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE. Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Eur J Pharm Biopharm; 2010 May; 75(1):71-8. PubMed ID: 19995604 [TBL] [Abstract][Full Text] [Related]
13. Characterization of physical mixtures and directly compressed tablets of sulfamerazine polymorphs: implications on in vitro release characteristics. Roy S; Alexander KS; Riga AT; Chatterjee K J Pharm Sci; 2003 Apr; 92(4):747-59. PubMed ID: 12661061 [TBL] [Abstract][Full Text] [Related]
14. Application of differential scanning calorimetry in evaluation of solid state interactions in tablets containing acetaminophen. Mazurek-Wadołkowska E; Winnicka K; Czajkowska-Kośnik A; Czyzewska U; Miltyk W Acta Pol Pharm; 2013; 70(5):787-93. PubMed ID: 24147356 [TBL] [Abstract][Full Text] [Related]
15. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone. Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787 [TBL] [Abstract][Full Text] [Related]
16. Influence of protein on mannitol polymorphic form produced during co-spray drying. Hulse WL; Forbes RT; Bonner MC; Getrost M Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563 [TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets. Aly SA; Udeala OK Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861 [TBL] [Abstract][Full Text] [Related]
18. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose. Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604 [TBL] [Abstract][Full Text] [Related]
19. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets. Patel H; Stalcup A; Dansereau R; Sakr A Int J Pharm; 2003 Oct; 264(1-2):35-43. PubMed ID: 12972334 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying. LeClair DA; Cranston ED; Xing Z; Thompson MR Int J Pharm; 2016 Jun; 506(1-2):289-301. PubMed ID: 27130366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]